辛伐他汀对大鼠血管平滑肌细胞增殖及FGFR1与p21ras表达的干预作用
- 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
辛伐他汀对大鼠血管平滑肌细胞增殖及FGFR1与p21ras表
达的干预作用
侯慧芳;刘国庆;王永玲;孙银平;郭勇
【期刊名称】《实用医学杂志》
【年(卷),期】2012(28)3
【摘要】目的:观察辛伐他汀对血管平滑肌细胞(VSMC)增殖中FGFRI、p21ras蛋白表达的影响.方法:体外培养大鼠VSMC,建立VSMC增殖模型,应用不同浓度的辛伐他汀干预,MTT法测定细胞增殖活力;免疫印迹法检测FGFR1与p21ras蛋白的表达.结果:与对照组比较.辛伐他汀各浓度组细胞增殖活力均显著降低(P<0.05);与对照组(FGFR1 208.07±10.70,p21ras 202.43±12.36)相比,低剂量组(FGFR1 181.47±7.43,p21ras 182.00±8.98)的FGFR1、p21ras表达差异无显著性(P>0.05),中剂量组(FGFR1 144.90±9.03,p21ras147.03±9.13)、高剂量组(FGFR1 104.43±8.08,p21ras 100.3 ±8.37)的表达均较明显降低(P<0.05),中、高剂量组FGFR1、p21ras表达较低剂量组均显著降低(P<0.05),高剂量组表达又较中剂量组显著降低(P<0.05),呈剂量依赖性.结论:辛伐他汀能抑制VSMC增殖,该作用是通过抑制FGFR1、p21ras蛋白表达实现的,这可能是辛伐他汀治疗动脉粥样硬化、再狭窄及高血压等心血管疾病的重要机制之一.%Objective To investigate the effect of simvastatin on the proliferations and the expressions of FGFR1 and
p21ras in rats vascular smooth muscle cells (VSMCs). Methods VSMCs were cultivated in vitro and VSMC models of proliferation were established in the study. The alive cells counting by tetrazolium dye-reduction assay (MTT) were use to determine the effect of simvastatin on VSMCs
proliferation at different concentrations (0, 1, 5, 10 μmol/L), the expressions of FGFR1 and p21ras were detected by Western blot methods. Results Compared with the control group, other simvastatin concentration groups were appeared different levels of growth inhibition (P < 0.05); Compared with the control group, the expressions of FGFR1, p21ras was unconspicuously changed in low dose group while the expressions were more significantly reduced in middle dose and high dose groups (P < 0.05); Compared with middle dose group, the expression was clearly reduced in high dose group group (P < 0.05), and there was a obvious dose dependency. Conclusions Simvastatin might play a role of inhibiting VSMCs proliferation by reducing the expression of FGFR1 and p21ras, it may be one of the important mechanisms that simvastatin treated cardiovascular disease such as atherosclerosis, restenosis and hypertension.【总页数】3页(P367-369)
【作者】侯慧芳;刘国庆;王永玲;孙银平;郭勇
【作者单位】453003,新乡医学院基础医学院病理生理学教研室;453003,新乡医学院基础医学院病理生理学教研室;453003,新乡医学院基础医学院病理生理学教研室;453003,新乡医学院基础医学院病理生理学教研室;453003,新乡医学院基础医学院病理生理学教研室
【正文语种】中文
【相关文献】
1.骨形态发生蛋白受体-Ⅱ在低氧大鼠肺血管中的表达及辛伐他汀的干预作用 [J], 夏秀琼;雒洪志;袁小玲;黄锡坤;郭伟洪;陈维
2.2型糖尿病性动脉粥样硬化大鼠血浆VEGF、TGF-β1、CTRP3的表达及辛伐他汀的干预作用 [J], 王婉秋;孙侃;靳瑾;周婷
3.颈总动脉损伤大鼠成纤维细胞生长因子受体1、p21ras表达与辛伐他汀的抑制效应 [J], 侯慧芳;刘国庆;孙银平;郭勇;王永玲
4.颈总动脉损伤大鼠成纤维细胞生长因子受体1、p21ras表达与辛伐他汀的抑制效应 [J], 侯慧芳;刘国庆;孙银平;郭勇;王永玲
5.川芎嗪对大鼠血管平滑肌细胞增殖及FGFR1与p21ras表达的干预作用 [J], 朱蓓蓓;王永玲;李彦;孙银平
因版权原因,仅展示原文概要,查看原文内容请购买。